• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Resmed Inc (NY: RMD )

    244.44 +1.97 (+0.81%)
    Streaming Delayed Price Updated: 2:42 PM EDT, Nov 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Resmed Inc

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    11 12 Next >
    P/E Ratio Insights for ResMed
    Via Benzinga
    Tech Stocks Rally As Investors Await Magnificent 7 Earnings; Dollar Eyes Fourth Straight Positive Week: What's Driving Markets Friday?
    Stocks are ending the week on a high note, with tech leading the charge as investors position ahead of next week’s pivotal earnings releases from five of the “Magnificent Seven” stocks. 
    Via Benzinga
    Stock Market Mixed But Nasdaq Hits Record High As Tesla Leads Earnings Winners: Weekly Review
    The major indexes were mixed for the week. 
    Via Investor's Business Daily
    Cracking The Code: Understanding Analyst Reviews For ResMed
    Via Benzinga
    Sleep Apnea Device Maker ResMed Is A Durable MedTech, With Positive Fundamentals, Says Analyst
    ResMed reports Q1 2025 adjusted EPS of $2.20, up 34%, beating estimates. Revenue reached $1.22 billion, up 11%, driven by demand growth. 
    Via Benzinga
    My 3 Favorite Stocks to Buy Right Now
    Here are three attractive stocks to buy that will give you a healthy mix of growth and dividends. 
    Via The Motley Fool
    Obesity Drugs-Tied ResMed Edges Higher On Quarterly Beat
    The company beat fiscal first-quarter expectations. Shares are forming a flat base. 
    Via Investor's Business Daily
    ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2025
    From ResMed Inc.
    Via GlobeNewswire
    A Peek at ResMed's Future Earnings
    Via Benzinga
    Is RESMED INC (NYSE:RMD) suited for quality investing?
    Analyzing the Quality Characteristics of RESMED INC (NYSE:RMD). 
    Via Chartmill
    Expert Outlook: ResMed Through The Eyes Of 7 Analysts
    Via Benzinga
    Reasonable growth and debt and a high ROIC for RESMED INC (NYSE:RMD).
    Why NYSE:RMD Stands Out as a Quality Stock. 
    Via Chartmill
    ResMed to Report First Quarter Fiscal 2025 Earnings on October 24, 2024
    From ResMed Inc.
    Via GlobeNewswire
    ResMed Unveils 2030 Strategy to Drive Growth, Profitability, and Shareholder Returns
    From ResMed Inc.
    Via GlobeNewswire
    UPDATE -- ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health
    From ResMed Inc.
    Via GlobeNewswire
    How Is The Market Feeling About ResMed?
    Via Benzinga
    Why Quality-Oriented Investors Should Consider NYSE:RMD.
    Exploring RESMED INC (NYSE:RMD)'s quality characteristics. 
    Via Chartmill
    UPDATE -- ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health
    The new AirTouch™ N30i tube-up nasal mask for CPAP combines softness, breathability, and a high-performance, durable seal to provide exceptional comfort 
    From ResMed Inc.
    Via GlobeNewswire
    ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health
    The new AirTouch™ N30i tube-up nasal mask for CPAP combines softness, breathability, and a high-performance, durable seal to provide exceptional comfort 
    From ResMed Inc.
    Via GlobeNewswire
    ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health
    From ResMed Inc.
    Via GlobeNewswire
    Wall Street's Top 10 Stock Calls This Week - Saturday, Sept. 21
    What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of Sept. 16-20, 2024. 
    Via Talk Markets
    Why ResMed Stock Tumbled by 5% Today
    A looming threat from a very powerful rival could significantly dampen a key business for the company. 
    Via The Motley Fool
    Stocks Edge Lower As Fed Rate Decision Looms, Treasury Yields Rise As Odds Improve For Smaller Cut: What's Driving Markets Wednesday?
    Wall Street is jittery hours before the highly anticipated Federal Open Market Committee (FOMC) meeting, with all major indices posting modest losses by midday in New York. 
    Via Benzinga
    Topics Economy
    Exposures Interest Rates
    ResMed to Host Its 2024 Investor Day on September 30, 2024, at the New York Stock Exchange
    From ResMed Inc.
    Via GlobeNewswire
    Vaping Expected to Increase COPD Health and Economic Burden by 2050
    From ResMed Inc.
    Via GlobeNewswire
    Here's How Much You Would Have Made Owning ResMed Stock In The Last 15 Years
    Via Benzinga
    A Glimpse Into The Expert Outlook On ResMed Through 6 Analysts
    Via Benzinga
    ResMed Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference
    From ResMed Inc.
    Via GlobeNewswire
    $1000 Invested In ResMed 10 Years Ago Would Be Worth This Much Today
    Via Benzinga
    RxSight Stock Sees Relative Strength Rating Rise To 91
    On Monday, RxSight stock earned a positive adjustment to its Relative Strength (RS) Rating, from 88 to 91. 
    Via Investor's Business Daily
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    11 12 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.